Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Phase 1/2 × Hormone Refractory Prostate Cancer × 90 days × Clear all

Phase

Phase 3 1 Phase 2 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 116 Breast Neoplasms 73 Neoplasms 69 Colorectal Neoplasms 62 Prostatic Neoplasms 53 Ovarian Neoplasms 50 Melanoma 47 Neoplasm Metastasis 46 Lung Neoplasms 43 Pancreatic Neoplasms 42 Multiple Myeloma 40 Recurrence 39 Leukemia, Myeloid, Acute 37 Stomach Neoplasms 35 Glioblastoma 32 Triple Negative Breast Neoplasms 31 Lymphoma 31 Squamous Cell Carcinoma of Head and Neck 30 Lymphoma, Non-Hodgkin 28 Lymphoma, Large B-Cell, Diffuse 27 Carcinoma, Renal Cell 27 Precursor Cell Lymphoblastic Leukemia-Lymphoma 26 Leukemia, Lymphocytic, Chronic, B-Cell 26 Endometrial Neoplasms 26 Sarcoma 25 Small Cell Lung Carcinoma 24 Myelodysplastic Syndromes 23 Uterine Cervical Neoplasms 22 Lymphoma, Follicular 22 Advanced Solid Tumors 21

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡